ロード中...
Long-term effects of fingolimod in multiple sclerosis: The randomized FREEDOMS extension trial
OBJECTIVE: To assess long-term safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (RRMS). METHODS: Patients completing FTY720 Research Evaluating Effects of Daily Oral Therapy in MS (FREEDOMS) were eligible for this dose-blinded, parallel-group extension study,...
保存先:
| 出版年: | Neurology |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Lippincott Williams & Wilkins
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4408283/ https://ncbi.nlm.nih.gov/pubmed/25795646 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000001462 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|